Selective opportunistic screening for hypercholesterolemia in primary care practice

Journal of Clinical Epidemiology

Volumn 51, Issue 10, 1998, Pages 817-825

  Hutchison, Brian ^a   Birch, Stephen ^a   Evans, C Edward ^a   Goldsmith, Laurie J ^a   Markham, Barbara A ^a   Frank, John ^b   Paterson, Michael ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

Hypercholesterolemia; Performance appraisal; Primary care; Screening

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; CANADA; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; GROUP PRACTICE; HUMANS; HYPERCHOLESTEROLEMIA; MASS SCREENING; MEDICAL AUDIT; MIDDLE AGED; ONTARIO; PATIENT SELECTION; PRIMARY HEALTH CARE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 17144432568     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00068-7     Document Type: Article

References (32)

1. 1. Reader BA, Dagenais GR, Johansen H, Lauzon R, Mao Y, Nair C, et al. Cardiovascular Disease in Canada 1993. Ottawa: Heart and Stroke Foundation of Canada; 1993: 3.
2. 2. OECD. Program OECD Health Data (Version 1.01, August 1991). Paris: OECD; 1991.
3. 3. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. 1. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-364.
4. 4. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki Heart Study: Primary prevention trial with genfibrozil in middle-aged men with dyslipidemia. N Engl J Med 1987; 317: 1237-1245.
5. 5. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307.
6. 6. Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Can Med Assoc J 1993; 148: 521-538.
7. 7. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Ann Intern Med 1979; 90: 1985-1991.
8. 8. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 1982; 248: 1465-1467.
9. 9. Coronary Prevention Group. Risk assessment in the prevention of coronary heart disease: A policy statement. Br J Gen Pract 1990; 40: 467-469.
10. 10. European Atherosclerosis Society Study Group. Strategies for the prevention of coronary heart disease. Eur Heart J 1987; 8: 77-88.
11. 11. International Task Force for the Prevention of Coronary Health Disease. Prevention of coronary heart disease: Scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society. Nutr Metab Cardiovasc Dis 1992; 2: 113-156.
12. 12. National Cholesterol Education Program Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-69.
13. 13. National Cholesterol Education Program Expert Panel. Second report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA 1993; 269: 3015-3023.
14. 14. Canadian Consensus Conference on Cholesterol. Final report. Can Med Assoc J 1988; 139 (Suppl): 1-8.
15. 15. Toronto Working Group on Cholesterol Policy. Detection and Management of Asymptomatic Hypercholesterolemia: A Policy Document. Toronto: Ontario Ministry of Health; 1989.
16. 16. Toronto Working Group on Cholesterol Policy. Asymptomatic hypercholesterolemia: A clinical policy review. J Clin Epidemiol 1990; 43: 1029-1121.
17. 17. American College of Physicians. Clinical guidelines, part 1. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996; 124: 515-517.
18. 18. Pyöralä K, DeBacker G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-1331.
19. 19. Royal College of General Practitioners. Guidelines for the Management of Hyperlipidaemia in General Practice: Towards the Primary Prevention of Coronary Heart Disease. Occasional paper 55. Exeter: The Royal College of General Practitioners; 1992.
20. 20. Hutchison B, Birch S, Evans CE, Goldsmith LJ, Markham BA, Frank J, Paterson M. Screening for hypercholesterolemia in primary care: Randomized controlled trial of postal questionnaire appraising risk of coronary heart disease. Br Med J 1998; 316: 1208-1213.
21. 21. Gardner SB, Winter PD, Gardner M. Confidence Interval Analysis (CIA) Version I.O. London: British Medical Journal; 1989.
22. 22. Smith GD, Song F, Sheldon TA. Cholesterol lowering and mortality: The importance of initial level of risk. Br Med J 1993; 306: 1367-1373.
23. 23. Law MR, Thompson SC, Wald NJ. Assessing possible hazards of reducing serum cholesterol. Br Med J 1994; 308: 373-379.
24. 24. Could AL, Rossouw JE, Santanello NC, Heyse JF, Furberg DC. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 1995; 91: 2274-2282.
25. 25. van der Weijden T, Dansen A, Schouten BJ, Knottnerus JA, Grol RPTM. Comparison of appropriateness of cholesterol testing in general practice with the recommendations of national guidelines: An audit of patient records in 20 practices. Quality Health Care 1996; 5: 218-222.
26. 26. Ovhed I, Odeberg H, Rästam L. Opportunistic screening for hypercholesterolemia with participants selected by the general practitioner. Inclusion and drop-out rate. Family Practice 1991; 8: 360-366.
27. 27. Hahn DL, Berger MG. Implementation of a systematic health maintenance protocol in a private practice. J Family Practice 1990; 31: 492-504.
28. 28. McMenamin JP. Screening for coronary heart disease risk among men in a general practice. N Z Med J 1995; 108: 167-168.
29. 29. OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: Implications for screening in primary care. Br Med J 1991; 302: 1057-1060.
30. 30. Mann JI, Lewis B, Shepherd J, Winder AF, Fenster S, Rose L, Morgan B. Blood lipid concentrations and other cardiovascular risk factors: Distribution, prevalence, and detection in Britain. Br Med J 1988; 296: 1702-1706.
31. 31. Sacks G, Marsden R. Evaluation of a practice-based programme of health checks: Financial cost and success at risk detection. J R C Gen Practit 1989; 39: 369-372.
32. 32. Jones J, Davies DH, Dove JR, Collinson MA, Brown PMR. Identification and treatment of risk factors for coronary heart disease in general practice: A possible screening model. Br Med J 1988; 296: 1711-1714.